Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes

作者：Rohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, Phyllis Thangaraj, Aline Pedroso Camargos, Fan Bu, Xiyu Ding, Akihiko Nishimura, Tara V. Anand, Faaizah Arshad, Clair Blacketer, Yi Chai, Shounak Chattopadhyay, Michael B. Cook, David A. Dorr, Talita Duarte‐Salles, Scott L. DuVall, Thomas Falconer, Tina French, Elizabeth E Hanchrow, Guneet Kaur, Wallis C. Y. Lau, Jing Li, Kelly Chenlei Li, Yuntian Liu, Yuan Lu, Kenneth K. C. Man, Michael Edwin Matheny, Nestoras Nicolas Mathioudakis, Jody‐Ann McLeggon, Michael F McLemore, Evan P. Minty, Daniel R. Morales, Paul G. Nagy, Anna Ostropolets, Andrea Pistillo, Thanh-Phuc Phan, Nicole L. Pratt, Carlen Reyes, Lauren Richter, Joseph S. Ross, Elise Ruan, Sarah L. Seager, Katherine Simon, Benjamin Viernes, Jianxiao Yang, Can Yin, Seng Chan You, Jin J. Zhou, Patrick B. Ryan, Martijn J. Schuemie, Harlan M. Krumholz, George M. Hripcsak, Marc A. Suchard · 发表于：Journal of the American College of Cardiology · 年份：2024 · DOI：10.1016/j.jacc.2024.05.069 · 被引用次数：43 · 研究领域：Diabetes Treatment and Management、Hyperglycemia and glycemic control in critically ill and hospitalized patients、Diabetes Management and Research